Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Devlin
    Devlin
  3. Lin
    Lin
  4. Papadopoulos
    Papadopoulos
  5. Politikos
    Politikos
  6. DeRespiris
    DeRespiris
  7. Jakubowski
    Jakubowski
  8. Naputo
    Naputo
  9. Papanicolaou
    Papanicolaou
  10. Perales
    Perales

Groups

  1. Bone Marrow Transplant (9)
  2. Center for Hematologic Malignancies (9)
  3. Department of Medicine (9)
  4. Hematologic Malignancies, Division of (9)
  5. DigITs Research Group (8)
  6. CTCR Scholars (6)
  7. Survivorship Research (6)
  8. Biostatistics Service (4)
  9. Clinical Pharmacy Specialists (4)
  10. Division of Subspecialty Medicine (4)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Valkal Bhatt"
  3. "Meeting abstract"
  4. "2019"
Formats
  1. Meeting Abstract (9)
Groups
  1. Bone Marrow Transplant (9)
  2. Center for Hematologic Malignancies (9)
  3. Department of Medicine (9)
  4. Hematologic Malignancies, Division of (9)
  5. DigITs Research Group (8)
  6. CTCR Scholars (6)

More Groups

People
  1. Valkal Bhatt (9)
  2. Molly Maloy (8)
  3. Sergio Giralt (8)
  4. Juliet Barker (6)
  5. Andrew Lin (4)
  6. Esperanza Papadopoulos (4)

More People

Years
  1. 2019 (9)
Publications
  1. Biology of Blood and Marrow Transplantation (8)
  2. Clinical Lymphoma, Myeloma and Leukemia (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Addition of tocilizumab to cyclosporine/ MMF for acute graft-vs-host disease (aGVHD) prophylaxis in adult double unit cord blood transplant (dCBT) recipients: Promising preliminary results of a phase II clinical trial
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Hanash, A. M.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Busulfan/melphalan/fludarabine (Bu/Mel/Flu) conditioning versus total body irradiation/thiotepa/cyclophosphamide (HFTBI/Thio/Cy) based conditioning in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing CD34-selected T-cell depleted allogeneic stem cell transplantation (alloSCT)
    Meeting Abstract

    Orozco, J. S.; Hilden, P.; Maloy, M. A.; Pappacena, J.; Buie, L. W.; Shaffer, B. C.; Papadopoulos, E. B.; Jakubowski, A. A.; Bhatt, V.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Meeting Abstract

    Maples, K. T.; Maloy, M. A.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir prophylaxis demonstrates high efficacy in adult cytomegalovirus (CMV) seropositive cord blood transplant (CBT) recipients: A comparison with pre-letermovir era CBT controls
    Meeting Abstract

    Lau, C.; Politikos, I.; Maloy, M. A.; Naputo, K.; Afuye, A.; Devlin, S. M.; Bhatt, V.; Giralt, S. A.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in allogeneic hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Adult cord blood transplantation (CBT) recipients have a high incidence of early acute kidney injury (AKI) and AKI increases long-term chronic kidney disease (CKD) risk
    Meeting Abstract

    Gutgarts, V.; Zheng, J.; Politikos, I.; Devlin, S. M.; Maloy, M. A.; Giralt, S. A.; Scordo, M.; Bhatt, V.; Glezerman, I.; Jaimes, E. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity analysis of propylene glycol-free melphalan (Evomela®) compared to propylene glycol-based melphalan hydrochloride in autologous hematopoietic cell transplantation for multiple myeloma
    Meeting Abstract

    DeRespiris, L.; Bhatt, V.; Lin, A.; Maloy, M. A.; Chung, D. J.; Landau, H.; Scordo, M.; Giralt, S. A.; Shah, G. L.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Pre-engraftment syndrome (PES) is frequent in double unit cord blood transplantation (dCBT) recipients and is potentiated by the addition of haplo-identical CD34+ cells
    Meeting Abstract

    Bhatt, V.; Devlin, S. M.; Maloy, M. A.; Mazis, C.; Naputo, K.; Giralt, S. A.; Politikos, I.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save